Issue 23 - The Cancer Letter

Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.

SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.

LOGIN SUBSCRIBE NOW

SEARCH DATE

SEARCH TEXT

Cancel

OK

Cancel

OK

Delete Account

Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below

ASCO's mCODE seeks to compose lingua franca for cancer informatics

ASCO 2019 through art

ASCO's Miller: mCODE will improve downstream analytics with essential cancer data elements

Big Data for outcomes and clinical research:
major advance or improvement needed

Henry Lynch, pioneer of hereditary cancer detection, dies at 91

In Brief

Tony Kerlavage named director of NCI CBIIT

Jeff Shilling named NCI's chief information officer

Jeff Settleman named senior VP, group head of oncology R&D at Pfizer

RWJBarnabas Health and Rutgers Cancer Institute announce $750M cancer pavilion in New Brunswick

Hackensack Meridian Health opens Center for Discovery and Innovation

Indiana University and MSK researchers receive $4.1 million grant from Cancer Moonshot

Funding Opportunities

DoD kidney cancer funding opportunities for FY2019

Clinical Roundup

Study finds link between Medicaid expansion and equity in cancer care

Long-term survival benefit shown for metastatic melanoma patients treated with Tafinlar + Mekinist

Venclexta + Gazyva combination meets primary endpoint for CLL

Pembrolizumab found safe in treating cancer patients with HIV

BMS announces first presentation of results for Opdivo + Yervoy in hepatocellular carcinoma

Lymphoma trial finds combination targeted therapy effective prior to chemotherapy

Enfortumab vedotin produced tumor response rate of 44% in bladder cancer

Researchers identify three-drug combination curbing growth in melanoma

Taiho Oncology and Servier present Lonsurf data

Drugs & Targets

FDA grants Priority Review for daratumumab combination in multiple myeloma

Caris Life Sciences partners with Debiopharm International SA

NCI Trials

NCI Trials for June

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login